Spyryx Biosciences, which is developing an inhaled peptide for the treatment of cystic fibrosis and other respiratory diseases, has announced the appointment of former Sunovion Head of Clinical Research Alistair Wheeler as Chief Medical Officer, a newly created position. Spyryx's SPX-101 is currently in Phase 1 development for the treatment of cystic fibrosis. … [Read more...] about Spyryx Biosciences appoints Alistair Wheeler as Chief Medical Officer
People
Anna Slater joins PrEP Biopharm as Head of CMC
Johnson & Johnson spinout PrEP Biopharm has announced that former GSK Global Head of Analytical Technologies Anna Slater has joined the company as Head of Chemistry, Manufacturing and Controls. At GSK, Slater had been a Senior Director in the global Inhaled Product & Device Technology Leadership Team, responsible for CMC development of inhaled and nasal products and … [Read more...] about Anna Slater joins PrEP Biopharm as Head of CMC
Hovione opens office in Japan
Spray-drying and DPI specialist Hovione announced the opening a new sales and customer support office in Osaka, Japan, saying that "The new office underlines the importance of Japan for Hovione's business activities. Japan is a strategic market for Hovione where the company is growing both its off patent API and its contract manufacturing businesses. The new office … [Read more...] about Hovione opens office in Japan
MVIC appoints Lars Asking as VP
The Medicon Valley Inhalation Consortium (MVIC) has announced the appointment of Lars Asking as VP as of May 1, 2016. Asking was most recently Principle Scientist at Novo Nordisk and previously developed inhaled products at LAB Pharma and AstraZeneca. MVIC is comprised of 24 member companies with expertise in various areas of inhaled product development. In … [Read more...] about MVIC appoints Lars Asking as VP
InCarda Therapeutics hires Luiz Belardinelli as CMO
InCarda Therapeutics, which is developing an inhaled treatment for paroxysmal atrial fibrillation, has appointed former Gilead Senior VP for Cardiovascular Therapeutics Luiz Belardinelli as Chief Medical Officer, the company said. Belardinelli will continue as a Senior Advisor for Gilead while working for InCarda half time. In April 2015, InCarda announced that … [Read more...] about InCarda Therapeutics hires Luiz Belardinelli as CMO
MannKind announces 4th quarter results, management changes
According to MannKind Corporation, the company's net loss for 2015 was $368.4 million, and its cash and cash equivalents as of the end of 2015 totaled $59.1 million. The company also said that it has hired former Amgen VP, Global Commercial Lead Michael E. Castagna as its Chief Commercial Officer, effective immediately, and announced the resignation of Chief Operating … [Read more...] about MannKind announces 4th quarter results, management changes
Tim Freeman receives Richard S. Ladd Standards Development Award from ASTM
Powder testing specialist Freeman Technology has announced that Managing Director Tim Freeman has received the Richard S. Ladd Standards Development Award from the ASTM for development of ASTM Standard Designation D7891 “Standard Test Method for Shear Testing of Powders using the Freeman Technology FT4 Powder Rheometer Shear Cell.” Freeman's FT4 powder rheometer is … [Read more...] about Tim Freeman receives Richard S. Ladd Standards Development Award from ASTM
MannKind founder Alfred Mann has died at age 90
MannKind Corporation has announced the death of founder and Chairman Emeritus Alfred Mann at age 90, one week after he stepped down as Chairman of the Board. Mann served as CEO from November 2003 until January 2015 and as Chairman of the Board of MannKind from 2001 until last week. According to the company, Mann's death will have no effect on business activities or … [Read more...] about MannKind founder Alfred Mann has died at age 90
Curida announces alliance with OINDP consultant René Bommer
Norwegian CDMO Curida, which offers a wide range of analytical, development, and manufacturing services for OINDPs, has announced a new strategic partnership with pharmAccel Consulting Director René Bommer. In July 2015, Curida acquired a nasal spray manufacturing facility in Elverum, Norway from Takeda, and the company cites Bommer's expertise in nasal spray … [Read more...] about Curida announces alliance with OINDP consultant René Bommer
Kent Kresa takes over as MannKind’s Chairman of the Board
MannKind Corporation has announced the resignation of Alfred Mann as Executive Chairman and the appointment of Kent Kresa as Chairman of the Board, effective immediately. Mann will continue as a non-executive advisor, the company said. Kresa is Chairman Emeritus of Northrop Grumman Corporation and has served on the boards of numerous companies, universities, and … [Read more...] about Kent Kresa takes over as MannKind’s Chairman of the Board